News und Analysen
2 REIT stocks set to surge due to red hot data center demand
If there’s one industry that’s set to outgrow pretty much all others in the coming years, it’s data centers. At the start of last year, McKinsey said they were expecting demand to grow by at least
2 REIT stocks set to surge due to red hot data center demand
If there’s one industry that’s set to outgrow pretty much all others in the coming years, it’s data centers. At the start of last year, McKinsey said they were expecting demand to grow by at least
3 reasons airline stocks are a buy right now
American Airlines Group Inc. (NASDAQ: AAL) is pulling back after its January 25 post-earnings gap higher. However, Wall Street sees reasons to buy not only American Airlines but other stocks in
Microsoft stock to $450? Here’s How
Microsoft’s (NASDAQ: MSFT) share price is driven by its growing position in the cloud. Late to the game, Microsoft has leaned hard into cloud and cloud services and AI, gaining share from Amazon
Microsoft stock to $450? Here’s How
Microsoft’s (NASDAQ: MSFT) share price is driven by its growing position in the cloud. Late to the game, Microsoft has leaned hard into cloud and cloud services and AI, gaining share from Amazon
Microsoft stock to $450? Here’s How
Microsoft’s (NASDAQ: MSFT) share price is driven by its growing position in the cloud. Late to the game, Microsoft has leaned hard into cloud and cloud services and AI, gaining share from Amazon
Microsoft stock to $450? Here’s How
Microsoft’s (NASDAQ: MSFT) share price is driven by its growing position in the cloud. Late to the game, Microsoft has leaned hard into cloud and cloud services and AI, gaining share from Amazon
3 big banking stocks that just got upgraded
With expectations rising for the Fed to cut rates sometime this year, banking stocks are very much back in focus. While it was looking like 2023 was going to go down as one of the poorer years in
Advanced Micro Devices is at a significant turning point
Advanced Micro Devices (NASDAQ: AMD) share price imploded following the Q4 release, but investors should not fear the move. The decline is a knee-jerk reaction to expected news, setting the market
Advanced Micro Devices is at a significant turning point
Advanced Micro Devices (NASDAQ: AMD) share price imploded following the Q4 release, but investors should not fear the move. The decline is a knee-jerk reaction to expected news, setting the market
Advanced Micro Devices is at a significant turning point
Advanced Micro Devices (NASDAQ: AMD) share price imploded following the Q4 release, but investors should not fear the move. The decline is a knee-jerk reaction to expected news, setting the market
2 upgraded food stocks with super-sized gain potential
If this week ends the way it started, the U.S. stock market will head into the weekend at fresh all-time highs.
Despite light news flow, the major indices posted heavy gains on Monday before
IBM, Verizon, Merck stocks lead Dow to new highs
You don't hear as much about the Dow Jones Industrial Average as investors did a few decades ago, as the broad consensus has deemed the S&P 500 a better indicator of market conditions.
But the
IBM, Verizon, Merck stocks lead Dow to new highs
You don't hear as much about the Dow Jones Industrial Average as investors did a few decades ago, as the broad consensus has deemed the S&P 500 a better indicator of market conditions.
But the
IBM stock jumps to 10-year high on accelerated AI growth
International Business Machines (NYSE: IBM) stock is trading at its best levels in nearly 10 years.
Take a look at the IBM chart: The stock is up 14.42% in the past month and up 32.47% in the
IBM stock jumps to 10-year high on accelerated AI growth
International Business Machines (NYSE: IBM) stock is trading at its best levels in nearly 10 years.
Take a look at the IBM chart: The stock is up 14.42% in the past month and up 32.47% in the
Med-tech stock Conmed dips ahead of big Q4 report...opportunity?
When Utica, NY-based medical technology company CONMED Corporation (NYSE:CNMD) reports fourth quarter financials after the close on Wednesday, it is expected to post some of its best growth in
4 med tech stocks with improving prognosis for 2024
Med tech stocks have been a mixed bag of results the last two years, with most moving within established trading ranges. The impact of COVID and its effect on procedure volumes were slow to
Starbucks perks up on margin strength: Are new highs in sight?
Starbucks Corporation (NASDAQ: SBUX) share prices perked up after the FQ1 release and guidance, but new highs are not in sight. The results were mixed, weak relative to the analysts' consensus
Starbucks perks up on margin strength: Are new highs in sight?
Starbucks Corporation (NASDAQ: SBUX) share prices perked up after the FQ1 release and guidance, but new highs are not in sight. The results were mixed, weak relative to the analysts' consensus
Starbucks perks up on margin strength: Are new highs in sight?
Starbucks Corporation (NASDAQ: SBUX) share prices perked up after the FQ1 release and guidance, but new highs are not in sight. The results were mixed, weak relative to the analysts' consensus
Crane can fly to new highs in 2024
Crane (NYSE: CR) is a high-flying stock, having gained 58% since the IPO spin-off and keeping most of it. A recent downshift in analyst sentiment driven by valuation capped gains in January
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 31205%
31.01.24 08:02
London (www.aktiencheck.de, Anzeige)
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 31205%
31.01.24 08:02
London (www.aktiencheck.de, Anzeige)
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Durchbruch in der Krebsforschung - 22% der Patienten vollständig geheilt. Neuer 250% Biotech Hot Stock nach 31205%
31.01.24 08:02
London (www.aktiencheck.de, Anzeige)